Related by context. Frequent words. (Click for all words.) 73 commercializing therapeutic 72 immunologic diseases 71 immunotherapeutics 70 therapeutic monoclonal antibodies 69 commercial bioproduction 69 Daclizumab 68 inflammatory autoimmune diseases 68 StromaCel Inc. 68 oncolytic viruses 67 metastatic colorectal 67 immuno inflammatory diseases 67 endocrine diseases 67 inflammation autoimmune diseases 67 theranostics 66 Amgen discovers develops 66 novel antibody therapeutics 66 hepatitis C lupus 66 identify protein biomarkers 66 fibrosis IPF 66 immunological diseases 66 gastrointestinal mucositis 66 R sorafenib tablets 66 Neogenix 66 BioMarin develops 66 lung pancreatic 66 Initiates Phase II 66 Agios Pharmaceuticals 65 topically delivered 65 Regado Biosciences 65 bio therapeutics 65 Amgen discovers develops manufactures 65 non personalized allogeneic 65 personalized immunotherapy 65 MultiCell Technologies 65 addressing idiopathic pulmonary 65 commercializes innovative biopharmaceuticals 65 Darinaparsin 65 recombinant vaccines 65 Chemokine Therapeutics 65 topical anti infective 65 PSMA ADC 65 Inc. Nasdaq NEXM 65 GVAX R 65 malignant infectious 65 Canvaxin 65 interstitial cystitis IC 64 drug conjugate 64 Genaera Corporation 64 ASG 5ME 64 autoimmune disorders asthma 64 Inc. Nasdaq SUPG 64 NovaBay Pharmaceuticals 64 biotherapy 64 theranostic 64 HepaLife Technologies Inc. 64 investigational therapies 64 Onalta 64 rheumatoid arthritis multiple sclerosis 64 CureDM 64 colorectal lung 64 thrombotic disorders 64 including nutritionals devices 64 Crohn disease rheumatoid arthritis 64 oncology therapeutics 64 fluoroquinolone class 64 developing Zerenex TM 64 Zenapax 64 imaging neurodegenerative disorders 63 VEGFR2 inhibitor 63 PEG SN# 63 IMC #B 63 please visit http:/www.supergen.com 63 Bayhill Therapeutics 63 novel RNAi therapeutics 63 cancer immunotherapies 63 Panzem R NCD 63 photodisinfection 63 CMV vaccine 63 ZFP Therapeutics 63 immune modulating 63 multi kinase inhibitor 63 human antibody therapeutics 63 ImmuneRegen BioSciences Inc. 63 CEQ# 63 ovarian breast 63 Inc. Nasdaq IMGN 63 Biomagnetics Diagnostics Corporation 63 PLK1 SNALP 63 Atrigel 63 VIA Pharmaceuticals 63 Panzem R 63 GRNVAC1 63 cardiovascular metabolic 63 refractory chronic lymphocytic 63 TLR9 agonist 63 oncology neurology 63 Callisto Pharmaceuticals Inc. 63 autoimmune inflammatory 63 www.vivus.com 62 Receives Orphan Drug Designation 62 molecular biomarkers